Outlook

  • Outlook |

    Paying for cancer immunotherapy will require new ways of cooperation between drug companies, insurers and policymakers, says Scott Ramsey.

    • Scott Ramsey
  • Outlook |

    Thousands of clinical trials are unleashing the power of the body's own defences against tumours.

    • Eric Bender
  • Outlook |

    The next generation of modified T-cell therapies is taking on solid tumours — but it’s an uphill fight.

    • Megan Scudellari
  • Outlook |

    On a global scale, reducing fossil-fuel dependence is more than just a technological challenge.

    • Michelle Grayson
  • Outlook |

    Community power projects in Denmark and Germany have inspired politicians worldwide but have failed to translate to other countries. Sometimes the first step is to let people say no.

    • Craig Morris
    •  & Arne Jungjohann
  • Outlook |

    All energy production has environmental and societal effects. But calculating them — and pricing energy accordingly — is no easy task.

    • Erica Gies
  • Outlook |

    Hybrid solar-diesel minigrids in Bangladesh are changing the lives of people in remote rural areas.

    • Lucas Laursen
  • Outlook |

    From elbow grease to electricity, horsepower to hydropower, energy has played a crucial part in shaping society.

    • Stephanie Pain
  • Outlook |

    Conventional detection of advanced fatty liver disease relies on biopsy. Less onerous methods may help to save lives.

    • Michael Eisenstein
  • Outlook |

    Not everyone with a fatty liver goes on to develop more advanced disease. Understanding what triggers the progression could lead to better treatments.

    • Sarah DeWeerdt
  • Outlook |

    Biotechnology start-ups and pharmaceutical giants alike are charging ahead to develop therapies for the most serious form of non-alcoholic fatty liver disease

    • Liam Drew
  • Outlook |

    Bladder cancer is more deadly in women than in men. That needs to change, say James McKiernan and Denise Asafu-Adjei.

    • James McKiernan
    •  & Denise Asafu-Adjei
  • Outlook |

    Mechele Leon, an associate professor of theatre at the University of Kansas in Lawrence, was diagnosed with bladder cancer in March 2016. After treatment, Leon was left with no bladder, a urostomy bag, and a story to tell — which became a one-woman play called Bladder Interrupted.

    • Tammy Worth